Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: 75 - You Need To See This

4 Auto Parts Stocks Racing Ahead With Bullish Potential Gains

The auto parts industry is expected to thrive in the upcoming months, given the rise in new vehicle sales, soaring EV sales, and the integration of advanced automotive technology. Given this backdrop, quality auto parts stocks Allison Transmission Holdings (ALSN), Compagnie Générale des Établissements Michelin (MGDDY), Garrett Motion (GTX), and…

StockNews.com

4 Bullish Airliner Stocks to Consider - Buy or Watch?

The airline industry is well-poised for continued growth thanks to surging passenger and air cargo demand amid rapid urbanization, globalization, and economic expansion. So, should you buy or watch airline stocks SkyWest (SKYW), International Consolidated Airlines (ICAGY), Controladora Vuela (VLRS), and Air Canada (ACDVF)? Read on….

StockNews.com

Bank of America (BAC) Braces for Earnings - Strategies for Investors

Bank of America (BAC), the second-largest U.S. lender, will publish its first-quarter earnings on April 16. With the bank’s net interest income expected to decline in the first quarter, should investors consider investing in the stock ahead of its earnings? Read on to learn my view.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Are Interactive Brokers (IBKR) and Bank of New York Mellon (BK) Set for a Q1 Earnings Surprise?

The financial services industry is booming with the growing demand for wealth management and digital banking services coupled with the rising adoption of advanced technologies like AI and machine learning. Amid this, let’s find out if financial stocks Interactive Brokers (IBKR) and Bank of New York Mellon (BK) are poised…

StockNews.com

How To Buy The Best Stocks At The Best Time

How to use the POWR Options approach of combining fundamental, technical and implied volatility analysis with a recent RIO trade as an example.

StockNews.com

3 Auto Stocks Investors Are Bullish on in April

The automotive industry is poised for substantial expansion, thanks to the rising demand for EVs and the adoption of advanced automotive technologies. Given this backdrop, it could be wise to buy top auto stocks BYD Company (BYDDY), PACCAR (PCAR), and AB (publ) (VLVLY). Read more.

StockNews.com

Top 3 Value Auto Stock Buys for April

This year, the automotive industry is likely to accelerate with soaring electric vehicle sales and infrastructure advancements. Hence, quality auto stocks Bayerische Motoren Werke (BMWYY), Volkswagen (VWAGY), and REV Group (REVG), which boast lower-than-industry valuation multiples, might be solid buys for April. Keep reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Will GOOGL and AMZN Reign Supreme Among Tech Stocks in 2024?

Amidst the ever-changing digital terrain and the ascent of artificial intelligence (AI), the future looks promising for tech behemoths Alphabet (GOOGL) and Amazon.com (AMZN). Yet, a pressing query looms: Can GOOGL and AMZN uphold their status as reigning tech stock champions this year? Let's delve deeper to uncover the answer.

StockNews.com

3 Software Buys Surging Toward April Success

The software industry has shown resilience, consistent growth, innovation, and adaptability to changing market demands and emerging technologies. Given the industry’s solid growth prospects, fundamentally strong software stocks Workday (WDAY), Akamai Technologies (AKAM), and Smartsheet (SMAR) could be ideal additions to your portfolio. Read on.

StockNews.com

Will TSLA and NIO Stocks Stage a Recovery in April?

Battery electric vehicle (BEV) makers are grappling with a demand slowdown, changing consumer preferences, chip shortages, a surge in demand for hybrid vehicles, and sales challenges. Amid this uncertain backdrop, will automakers Tesla, Inc. (TSLA) and NIO Inc. (NIO) stage a recovery? Let’s discuss.

StockNews.com

3 Promising Biotech Stocks Driving Weekly Gains

The biotech industry’s prospects appear promising due to government support, regulatory changes, innovative therapies, and a focus on personalized medicine. Therefore, investors could consider buying fundamentally strong biotech stocks such as United Therapeutics (UTHR), TRACON Pharmaceuticals (TCON), and Corcept Therapeutics (CORT). Read more.

StockNews.com

3 Biotech Stocks to Invest In Right Now for Long-Term Gains

With the rapidly growing demand for personalized medicine, innovative solutions, and recent developments like AI in drug discovery, the biotech industry's prospects appear robust. Thus, quality biotech stocks Vertex Pharmaceuticals (VRTX), SIGA Technologies (SIGA), and Gilead Sciences (GILD) could be ideal candidates to buy now. Read more….

StockNews.com

Inflation Not Fading Fast Enough for Stock Investors

Investors may have celebrated the end of high inflation too soon. The CPI report shows inflation bouncing higher and thus pushing back the start date for Fed rate cuts. This has the S&P 500 (SPY) coming off recent highs. This begs questions like how much more downside could we see?…

StockNews.com

3 Energy Stocks Poised for Profits in April

The energy sector is expected to grow significantly due to geopolitical tensions, supply constraints, and rising global demand for natural gas and crude oil. Therefore, fundamentally strong energy stocks Enterprise Products Partners (EPD), Koninklijke Vopak (VOPKY), and VAALCO Energy (EGY) could be worth adding to your portfolio. Read on.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Affordable Pharma Stocks to Buy for Portfolio Gains

The pharmaceutical market is anticipated to grow substantially in the upcoming years, owing to technological innovation and rising demand for personalized medicines. To that end, affordable pharma stocks ACADIA Pharmaceuticals (ACAD), Astellas Pharma (ALPMY), and Spero Therapeutics (SPRO), trading under $20, could be solid buys now. Read on….

StockNews.com

3 Telecom Gems for Portfolio Diversification

The telecom industry is poised for significant expansion, driven by rising demand for high-speed connectivity, ongoing innovations, and the rapid growth of 5G networks. Therefore, for portfolio diversification, investors could consider buying fundamentally strong telecom stocks Orange (ORAN), América Móvil (AMX), and KT Corporation (KT). Read more.

StockNews.com

3 Top-Rated Tech Stock Buys for Value in April

The technology sector is undergoing a notable surge, propelled by increasing digitalization endeavors among businesses and governmental support for technological progress. So, fundamentally sound tech stocks Box Inc. (BOX), Teradata (TDC), and Materialise (MTLS), which seem pretty undervalued, might be ideal buys this month. Continue reading.

StockNews.com

3 Auto Stocks to Consider Over TSLA in April

Tesla (TSLA) reported a decline in deliveries in the first quarter, and Wall Street expects the company to deliver fewer vehicles than last year. Furthermore, rising competition, slowing EV sales, and stretched valuation make TSLA unattractive from an investment standpoint. Considering these factors, investors could consider buying fundamentally strong auto…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Top Software Stocks at the Forefront of Market Gains

The software industry's prospects appear bright due to increasing investments in digital transformation, high demand for advanced software services from various sectors, and the integration of emerging technologies such as generative AI. Therefore, investors could consider buying quality software stocks Autodesk (ADSK), DocuSign (DOCU), and Pegasystems (PEGA) for solid gains.…

StockNews.com

3 Pharma Stocks Delivering Exciting April Returns

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on.

StockNews.com

3 Biotech Gems Poised for April Breakthroughs

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more….

StockNews.com

3 Biotech Stocks Gaining Altitude and Interest

This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy prospects, biotech stocks BioMarin Pharmaceutical (BMRN), ANI Pharmaceuticals (ANIP), and Genmab A/S (GMAB), gaining significant altitude and interest, could be ideal buys. Read on.

StockNews.com

3 A-Rated Pharma Stocks to Boost Your Bottom Line

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong…

StockNews.com

Top 3 Energy Stocks Locking in April Gains

The escalating geopolitical worries, tightened oil supplies, and increased oil consumption have bolstered the energy market. Given this backdrop, quality energy stocks Ultrapar Participações S.A. (UGP), Precision Drilling Corporation (PDS), and Adams Resources & Energy (AE) could be wise portfolio additions for potential gains this month. Read on….

StockNews.com

Is Citigroup (C) Poised for a Rebound After Earnings?

Citigroup (C), the third-biggest U.S. bank by assets, will publish its first-quarter earnings on April 12. C has undergone an overhaul with several key restructuring initiatives across its business over the past year. Is the bank poised for rebound post-earnings? Read on to learn my view.

1 … 74 75 76 77

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.